{"version":"1.0","provider_name":"Pharmex","provider_url":"https:\/\/pharmex.me\/en","author_name":"Exhibition Secretariat","author_url":"https:\/\/pharmex.me\/en\/author\/adminn\/","title":"Middle East Pharmaceutical Outlook Report 2025\u20132026 - Pharmex","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"to7oIVx2t9\"><a href=\"https:\/\/pharmex.me\/en\/2025\/12\/06\/middle-east-pharmaceutical-outlook-report-2025-2026\/\">Middle East Pharmaceutical Outlook Report 2025\u20132026<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/pharmex.me\/en\/2025\/12\/06\/middle-east-pharmaceutical-outlook-report-2025-2026\/embed\/#?secret=to7oIVx2t9\" width=\"600\" height=\"338\" title=\"&#8220;Middle East Pharmaceutical Outlook Report 2025\u20132026&#8221; &#8212; Pharmex\" data-secret=\"to7oIVx2t9\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/pharmex.me\/en\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/pharmex.me\/en\/wp-content\/uploads\/2025\/12\/photo_5881913645967543414_y.webp","thumbnail_width":900,"thumbnail_height":700,"description":"Published by: Pharmex Middle East (Aland Institute) Region Covered: Middle East, North Africa, CIS, South Asia The Middle East pharmaceutical sector is entering a period of accelerated transformation driven by population growth, increasing healthcare expenditure, government localization programs, and rising demand for Active Pharmaceutical Ingredients (APIs), machinery, and advanced manufacturing technologies. Between 2024\u20132028, the pharmaceutical [&hellip;]"}